INGN Stock Summary and Trading Ideas (Inogen | NASDAQ:INGN)

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Inogen trades on the NASDAQ stock market under the symbol INGN.

As of December 26, 2025, INGN stock price climbed to $6.80 with 145,699 million shares trading.

INGN has a beta of 0.96, meaning it tends to be less sensitive to market movements. INGN has a correlation of 0.11 to the broad based SPY ETF.

INGN has a market cap of $184.61 million. This is considered a Micro Cap stock.

Last quarter Inogen reported $92 million in Revenue and -$.02 earnings per share. This beat revenue expectation by $70,000 and exceeded earnings estimates by $.12.

In the last 3 years, INGN traded as high as $26.11 and as low as $4.13.

The top ETF exchange traded funds that INGN belongs to (by Net Assets): VTI, IWM, VXF, IWN, DFAT.

INGN has underperformed the market in the last year with a price return of -20.9% while the SPY ETF gained +16.0%. INGN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -17.3% and -3.7%, respectively, while the SPY returned +4.6% and +1.5%, respectively.

INGN support price is $6.51 and resistance is $6.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INGN shares will trade within this expected range on the day.